Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment. (2019)

First Author: Saengnipanthkul S
Attributed to:  Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/1756-185x.13068

PubMed Identifier: 28332780

Publication URI: http://europepmc.org/abstract/MED/28332780

Type: Journal Article/Review

Volume: 22

Parent Publication: International journal of rheumatic diseases

Issue: 3

ISSN: 1756-1841